Department of Biochemistry, University of Missouri, 117 Schweitzer Hall, Columbia, MO, 65211, USA.
Department of Child Health, University of Missouri, Columbia, MO, 65211, USA.
Curr Osteoporos Rep. 2018 Aug;16(4):478-489. doi: 10.1007/s11914-018-0456-6.
Osteogenesis imperfecta (OI) is a hereditary connective tissue disorder of skeletal fragility and more recently muscle weakness. This review highlights our current knowledge of the impact of compromised OI muscle function on muscle-bone interactions and skeletal strength in OI.
The ramifications of inherent muscle weakness in OI muscle-bone interactions are just beginning to be elucidated. Studies in patients and in OI mouse models implicate altered mechanosensing, energy metabolism, mitochondrial dysfunction, and paracrine/endocrine crosstalk in the pathogenesis of OI. Compromised muscle-bone unit impacts mechanosensing and the ability of OI muscle and bone to respond to physiotherapeutic and pharmacologic treatment strategies. Muscle and bone are both compromised in OI, making it essential to understand the mechanisms responsible for both impaired muscle and bone functions and their interdependence, as this will expand and drive new physiotherapeutic and pharmacological approaches to treat OI and other musculoskeletal disorders.
成骨不全症(OI)是一种遗传性结缔组织疾病,表现为骨骼脆弱,最近还出现肌肉无力。本文重点介绍了目前对 OI 肌肉功能障碍对肌肉骨骼相互作用和骨骼强度的影响的认识。
OI 肌肉骨骼相互作用中固有肌肉无力的影响才刚刚开始阐明。在患者和 OI 小鼠模型中的研究表明,机械敏感性改变、能量代谢、线粒体功能障碍和旁分泌/内分泌串扰参与了 OI 的发病机制。肌肉骨骼单位受损会影响机械敏感性以及 OI 肌肉和骨骼对物理治疗和药物治疗策略的反应能力。OI 中肌肉和骨骼均受到影响,因此必须了解导致肌肉和骨骼功能受损及其相互依存的机制,这将扩展和推动新的物理治疗和药物治疗方法来治疗 OI 和其他肌肉骨骼疾病。